Mega Genomics plans IPO in Hong Kong to counter growing popularity of genetic testing

Mega Genomics plans IPO in Hong Kong to counter growing popularity of genetic testing Markets By Sydney Barrett On Jun 16, 2022 Share The central theses: Mega Genomics intends to list approximately 11.9 million shares at HK$18-22 a share on June 23 in Hong Kong Although the company's net income hasn't grown over the past year amid pressure on margins, it has remained profitable, unlike publicly traded competitors New Horizon Health and Burning Rock Biotech By Molly Wen The popularity of genetic testing is growing rapidly in an increasingly health-conscious China. To the Mega Genomics Ltd. (6667.HK), this trend presents…